1613619-58-1Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Paragraph 0547; 0548; 0549; 0550, (2014/06/25)
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HNE is implicated.
NOVEL COMPOUNDS
-
Page/Page column 84-85, (2014/07/08)
This invention relates to heterocyclic compounds, which are pyrimidinone derivatives having human neutrophil elastase inhibitory properties, and their use in therapy.
